Literature DB >> 21479893

Epidemiology of mesothelioma and historical background.

J E Craighead1.   

Abstract

Mesothelioma is a "new" malignant disease strongly associated with exposure to amphibole asbestos exposure (amosite and crocidolite) environmentally and in the work place. Nonetheless, in recent years, we have learned that many cases of mesothelioma are idiopathic, while some are caused by therapeutic irradiation or chronic inflammation in body cavities. This paper reviews the key epidemiological features of the malignancy in the context of the biological and mineralogical factors that influence mesothelioma development. These tumors challenge the diagnostic pathologist's acumen, the epidemiologist's skill in devising meaningful and definitive studies, the industrial hygienist's knowledge of environmental hazards in diverse occupational settings, and the clinician's skill in managing an intrepid and uniformly fatal malignancy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21479893     DOI: 10.1007/978-3-642-10862-4_2

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  7 in total

Review 1.  Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health.

Authors:  Volker Neumann; Stefan Löseke; Dennis Nowak; Felix J F Herth; Andrea Tannapfel
Journal:  Dtsch Arztebl Int       Date:  2013-05-03       Impact factor: 5.594

Review 2.  [Morphological diagnostics of malignant pleural mesothelioma].

Authors:  K Junker; K-M Müller
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

3.  Improved Method for Analysis of Airborne Asbestos Fibers Using Phase Contrast Microscopy and FTIR Spectrometry.

Authors:  Mansour R Azari; Asil Yazdian; Rezvan Zendehdel; Hamid Souri; Soheila Khodakarim; Habibalalah Peirovi; Davod Panahi; Marzieh Kazempour
Journal:  Tanaffos       Date:  2014

Review 4.  Pemetrexed Maintenance Therapy Following Bevacizumab-Containing First-Line Chemotherapy in Advanced Malignant Pleural Mesothelioma: A Case Report and Literatures Review.

Authors:  Xu-Quan Jing; Lei Zhou; Xin-Dong Sun; Jin-Ming Yu; Xue Meng
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells.

Authors:  Mara A Bonelli; Graziana Digiacomo; Claudia Fumarola; Roberta Alfieri; Federico Quaini; Angela Falco; Denise Madeddu; Silvia La Monica; Daniele Cretella; Andrea Ravelli; Paola Ulivi; Michela Tebaldi; Daniele Calistri; Angelo Delmonte; Luca Ampollini; Paolo Carbognani; Marcello Tiseo; Andrea Cavazzoni; Pier Giorgio Petronini
Journal:  Neoplasia       Date:  2017-07-11       Impact factor: 5.715

6.  Malignant mesothelioma after household exposure to asbestos.

Authors:  Raya Saba; Godson Nnamdi Aronu; Ravinder Pal Bhatti; Aibek E Mirrakhimov; Nwabundo Anusim; Aram Barbaryan; Shawn G Kwatra; Nkemakolam Iroegbu
Journal:  Case Rep Oncol Med       Date:  2013-10-10

7.  Malignant Peritoneum Mesothelioma with Hepatic Involvement: A Single Institution Experience in 5 Patients and Review of the Literature.

Authors:  Shan-Shan Su; Guo-Qi Zheng; Ya-Gang Liu; Yue-Feng Chen; Zhao-Wei Song; Shu-Jing Yu; Ning-Ning Sun; Yu-Xin Yang
Journal:  Gastroenterol Res Pract       Date:  2016-03-16       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.